1. Home
  2. VIR vs PLUG Comparison

VIR vs PLUG Comparison

Compare VIR & PLUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • PLUG
  • Stock Information
  • Founded
  • VIR 2016
  • PLUG 1997
  • Country
  • VIR United States
  • PLUG United States
  • Employees
  • VIR N/A
  • PLUG N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • PLUG Industrial Machinery/Components
  • Sector
  • VIR Health Care
  • PLUG Energy
  • Exchange
  • VIR Nasdaq
  • PLUG Nasdaq
  • Market Cap
  • VIR 844.9M
  • PLUG 1.0B
  • IPO Year
  • VIR 2019
  • PLUG 1999
  • Fundamental
  • Price
  • VIR $5.41
  • PLUG $0.85
  • Analyst Decision
  • VIR Strong Buy
  • PLUG Hold
  • Analyst Count
  • VIR 7
  • PLUG 17
  • Target Price
  • VIR $33.57
  • PLUG $2.19
  • AVG Volume (30 Days)
  • VIR 1.0M
  • PLUG 106.6M
  • Earning Date
  • VIR 05-07-2025
  • PLUG 05-12-2025
  • Dividend Yield
  • VIR N/A
  • PLUG N/A
  • EPS Growth
  • VIR N/A
  • PLUG N/A
  • EPS
  • VIR N/A
  • PLUG N/A
  • Revenue
  • VIR $20,861,000.00
  • PLUG $628,814,000.00
  • Revenue This Year
  • VIR N/A
  • PLUG $26.39
  • Revenue Next Year
  • VIR $10.65
  • PLUG $25.44
  • P/E Ratio
  • VIR N/A
  • PLUG N/A
  • Revenue Growth
  • VIR N/A
  • PLUG N/A
  • 52 Week Low
  • VIR $4.95
  • PLUG $0.76
  • 52 Week High
  • VIR $14.45
  • PLUG $4.90
  • Technical
  • Relative Strength Index (RSI)
  • VIR 35.98
  • PLUG 38.74
  • Support Level
  • VIR $5.83
  • PLUG $0.76
  • Resistance Level
  • VIR $6.29
  • PLUG $1.19
  • Average True Range (ATR)
  • VIR 0.31
  • PLUG 0.09
  • MACD
  • VIR 0.02
  • PLUG 0.02
  • Stochastic Oscillator
  • VIR 28.80
  • PLUG 21.02

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About PLUG Plug Power Inc.

Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage, and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets, including material handling, e-mobility, power generation, and industrial applications.

Share on Social Networks: